Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
DRTS
DRTS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DRTS News
Alpha Tau Medical to Discuss Interim Data on Brain Cancer Treatment
1d ago
stocktwits
Alpha Tau Medical Reports Promising Trial Results for Glioblastoma Treatment
20h ago
stocktwits
Alpha Tau Medical Shares Surge 12% on Positive Glioblastoma Trial Results
21h ago
NASDAQ.COM
Trump Rejects Iran's Revised Proposal Amid Geopolitical Tensions
1d ago
stocktwits
Alpha Tau Announces Interim Clinical Data for Alpha DaRT
3d ago
Newsfilter
Alpha Tau Completes Enrollment in Pivotal U.S. Trial
3d ago
Newsfilter
Alpha Tau Medical Presents New Therapy at Head and Neck Cancer Conference
6d ago
Newsfilter
Alpha DaRT Achieves Milestone in Pancreatic Cancer Trials
May 04 2026
Newsfilter
ALPHA TAU REPORTS COMPLETE LOCAL DISEASE CONTROL AND POSITIVE SAFETY PROFILE IN ALPHA DART® PANCREATIC CANCER TRIALS SHOWCASED AT DDW 2026
May 04 2026
moomoo
Alpha Tau Medical Announces Key Research Accepted at ASCO Annual Meeting
Apr 27 2026
Newsfilter
Alpha Tau Medical Advances Pancreatic Cancer Research with Trial Expansion
Apr 24 2026
stocktwits
Launch of ACAPELLA Clinical Trial for LAPC
Apr 23 2026
Newsfilter
Alpha Tau Expands Pancreatic Cancer Clinical Trial
Apr 23 2026
Newsfilter
Alpha Tau Medical to Present Clinical Trial Results at DDW 2026
Mar 31 2026
Newsfilter
Alpha Tau Medical Advances Clinical Trials for Cancer Treatments
Mar 30 2026
stocktwits
Alpha Tau Medical Reports FY GAAP EPS of -$0.42
Mar 09 2026
seekingalpha
Show More News
